Recombinant pig cutaneous development substance (rEGF) is gaining increased recognition as a key strategy in the field of tissue medicine. This biological molecule, manufactured through molecular technology, delivers a https://recombinantporcineegf613717.pages10.com/recombinant-swine-cutaneous-development-substance-a-powerful-tool-for-cellular-regeneration-78451074